CDK8 and metastatic neoplasm: While both primary and metastatic tumors exhibited a full range of CDK8 distribution, the CDK8 and Ki67 (Figure 1(Bii)) immunoreactivities in the metastatic tissues were concentrated qualitatively in the tumoral and cystic regions.